BIG PHARMA EARNINGS WATCH: SANOFI, ABBVIE, PFIZER & AMGEN
New Round of Q3 Earnings Reports Continue to Show Big Pharma Profits Buoyed By… Read More
© 2026 CSRXP- All Rights Reserved
BIG PHARMA WATCH: BIG PHARMA SPENDS $263M ON LOBBYING, CAMPAIGN DONATIONS FIGHTING SOLUTIONS TO LOWER RX PRICES
New Analysis Highlights How Big Pharma Uses Limitless Resources… Read More
CSRXP APPLAUDS INCLUSION OF PRESCRIPTION DRUG PRICING SOLUTIONS IN LATEST FRAMEWORK
Congress Should Reject Pharma-backed Proposals That Would Hike Health Care… Read More
BIG PHARMA EARNINGS WATCH: NOVARTIS, MERCK, GLAXO SMITH KLINE, BRISTOL-MYERS SQUIBB
New Q3 Earnings Reports Underscore How Price Hikes, Anti-Competitive Tactics… Read More
CSRXP: WHITE HOUSE FRAMEWORK FAILS ON PROMISE TO LOWER DRUG PRICES
Framework Fails to Hold Big Pharma Accountable and Lower Drug Prices for the… Read More
ICYMI: NEW STUDY FINDS BIG PHARMA SPENT MORE ON SALES AND MARKETING THAN R&D DURING PANDEMIC
AHIP Study Finds Top Drug Companies’ Sales and Marketing Budgets Swamp… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, ROCHE
First Round of Q3 Earnings Reports Show Big Pharma Companies Raking in Big… Read More
WHAT THEY ARE SAYING: AMERICANS NATIONWIDE CALL ON CONGRESS TO LOWER RX PRICES NOW
Broad Array of Leaders Encourage Lawmakers to Capitalize on Unprecedented… Read More
CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOSIMILAR FOR HUMIRA AS POSITIVE FIRST STEP
U.S. Food & Drug Administration Approval of Cyltezo Marks Second… Read More
ICYMI: AARP POLL FINDS OVERWHELMING MAJORITY OF ARIZONA VOTERS WANT SOLUTIONS TO LOWER RX PRICES
New Survey Contributes to Unprecedented Momentum for Congress to Hold Big… Read More
ICYMI: VOTERS EXPECT CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE AND LOWER DRUG PRICES
Voters Expect Congress to Hold Big Pharma Accountable and Lower Drug Prices… Read More
CSRXP ENCOURAGES HOUSE JUDICIARY COMMITTEE TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE
Committee Mark Up Targets Brand Name Drug Companies’ Anti-Competitive… Read More